Bionano Genomics Inc
NASDAQ:BNGO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Bionano Genomics Inc
Bionano Genomics Inc
Capital Expenditures
Bionano Genomics Inc
Capital Expenditures Peer Comparison
TMO
DHR
MTD
A
IQV
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bionano Genomics Inc
NASDAQ:BNGO
|
Capital Expenditures
-$1.4m
|
CAGR 3-Years
-308%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Capital Expenditures
-$1.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-16%
|
|
|
Danaher Corp
NYSE:DHR
|
Capital Expenditures
-$1.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Capital Expenditures
-$99.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Capital Expenditures
-$358m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-7%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Capital Expenditures
-$630m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-24%
|
See Also
What is Bionano Genomics Inc's Capital Expenditures?
Capital Expenditures
-1.4m
USD
Based on the financial report for Mar 31, 2024, Bionano Genomics Inc's Capital Expenditures amounts to -1.4m USD.
What is Bionano Genomics Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-308%
Over the last year, the Capital Expenditures growth was 24%. The average annual Capital Expenditures growth rates for Bionano Genomics Inc have been -308% over the past three years .
You don't have any saved screeners yet
